Popular Articles

Mylan Receives FDA Approval For Generic Version Of Thyroid Deficiency Treatment Cytomel(R)
Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).
drugs without prescription
Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results For Radezolid In Community-Acquired Pneumonia
Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive results from a Phase 2 clinical trial of radezolid in the treatment of community-acquired pneumonia (CAP).
News of the day
Limited Data Suggest Possible Association Between Agent Orange Exposure And Ischemic Heart Disease And Parkinson's Disease In Vietnam Veterans
A new report from the Institute of Medicine finds suggestive but limited evidence that exposure to Agent Orange and other herbicides used during the Vietnam War is associated with an increased chance of developing ischemic heart disease and Parkinson"s disease for Vietnam veterans. The report is the latest in a congressionally mandated series by the IOM that every two years reviews the evidence about the health effects of these herbicides and a type of dioxin -- TCDD -- that contaminated some of the defoliants.
Public Health

Editorials Discuss Reform, Taxation Of Health Benefits

USA Today: It is "gratifying" that Republicans last week introduced a health care proposal because "the simple fact that it exists might improve chances" for bipartisan negotiations, a USA Today editorial states. According to the editorial, the plan -- which would replace the current tax exemption of employer-provided insurance with a refundable tax credit for all families and individuals, regardless of their employment status -- is "no cure-all," but is a "serious proposal that merits serious consideration." The editorial states, "For all those who say the Republican Party is out of ideas, on the issue of health coverage, at least, its proposal is bolder than what the Democrats have offered." However, the editorial notes that both Republicans and Democrats "have identified more groundbreaking ideas, and they are not entirely incompatible." The editorial concludes, "[L]et the debate begin. The only unacceptable approach is the status quo" (USA Today, 5/29). Wall Street Journal: The "emerging 180-degree turn by Democrats on taxes and health insurance is one for the record books," a Journal editorial states. According to the editorial, "Democrats have spent years arguing that proposals to equalize the tax treatment of health insurance are an outrage against the American people." However, "now Democrats need the money to finance $1.2 trillion or more for their new health insurance entitlement" and are considering taxing health insurance, according to the editorial. The editorial continues, "Democrats owe an apology" to Sen. John McCain (R-Ariz.), who favored taxing health benefits during his campaign and was "mauled" by liberals who criticized the idea as a tax hike on the middle class in "brutal" television ads. The editorial states, "Having told the country that this tax reform is really a tax increase, Democrats are opening themselves to the same attacks they leveled against Republicans." The editorial concludes that the only way Democrats can pay for their goal of "government-run health care" is "by taxing everything in sight, including your current health insurance" (Wall Street Journal, 5/29). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):